XORTX Therapeutics Inc.
Price Action
Technical Summary
WEAKENINGXORTX Therapeutics Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 17), showing significant lag compared to the market leaders. Earnings growth of 88% provides fundamental context to the price action. Investors should exercise caution due to high volatility (129% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.18 | +0.50% | ABOVE |
| 50 SMA | $2.41 | -9.21% | BELOW |
| 100 SMA | $2.27 | -3.44% | BELOW |
| 150 SMA | $2.48 | -11.75% | BELOW |
| 200 SMA | $2.80 | -21.91% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is XRTX in an uptrend right now?
XRTX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is XRTX overbought or oversold?
XRTX's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.
Is XRTX outperforming the market?
XRTX has a Relative Strength (RS) Rating of 17 out of 99. XRTX is currently lagging the broader market.
Where is XRTX in its 52-week range?
XRTX is trading at $2.19, which is 31% of its 52-week high ($7.05) and 25% above its 52-week low ($0.55).
How volatile is XRTX?
XRTX has a Beta of 0.81 and 52-week volatility of 129%. It's less volatile than the S&P 500 - generally more stable.